Clinical Trial Update: A Study of Afatinib in Patients With Advanced Cancer With Changes in the HER Gene [Phase 2]

View source ↗

Summary

Phase 2 study evaluating afatinib in patients with advanced cancer exhibiting HER gene changes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Solid Tumors | Phase 2 | Status: COMPLETED